Research Study2025

An exploratory qualitative study of barriers and facilitators to mobile addiction treatment (MAT) for opioid use disorder.

Muncan, Brandon; Williams, Robert; Engelman, Anya; Cheng, Eileen; Mukherjee, Trishna; Jordan, Ashly; Walters, Scott M.

SUD/Harm Reduction
↗ View original study
Authors
Muncan, Brandon; Williams, Robert; Engelman, Anya; Cheng, Eileen; Mukherjee, Trishna; Jordan, Ashly; Walters, Scott M.
Journal
Drug and Alcohol Dependence
Year
2025
Study design
Qualitative
Setting
Urban
Population
People Who Use Drugs
Outcome domain
Implementation/Operations
Type of organization
Academic

Abstract

Semi-structured interviews with 26 stakeholders (staff, patients, community members) of two mobile methadone clinics in New York City and Las Vegas explored barriers and facilitators to mobile addiction treatment (MAT). Key facilitators included flexibility of location/timing, reduced stigma, integrated services, and trusted relationships. Barriers included limited space, legal restrictions around methadone, and community opposition to program siting (NIMBYism).

Cite this study:Muncan, Brandon; Williams, Robert; Engelman, Anya; Cheng, Eileen; Mukherjee, Trishna; Jordan, Ashly; Walters, Scott M. (2025). An exploratory qualitative study of barriers and facilitators to mobile addiction treatment (MAT) for opioid use disorder. Drug and Alcohol Dependence. https://doi.org/https://pubmed.ncbi.nlm.nih.gov/39625067/
↗ View original study
Metadata curated by Mission Mobile Medical. Full text is available from the publisher via the DOI link above.